Market Intel
2026-07-01 at 9:41am
June 2026 marked a busy close to the quarter for the SPAC market, with activity building across extensions, completion votes, IPO issuance, and new deal announcements. Extension activity was driven by a large number of first-time votes, while completion vote activity picked up and deal announcements remained active, led primarily by technology with support from several other sectors. ...
2026-07-01 at 8:28am
At the SPAC of Dawn The second quarter is officially in the books and SPAC watchers can now take a step back and take a look at how it shaped up by the numbers. ...
2026-07-01 at 6:01am
An In-Depth Look at SPAC Activity in Q2-2026 Below is a summary of the Q2- 2026 SPAC market. If you'd like a pdf copy, you can access the link HERE. After a white-hot SPAC IPO market in Q1, Q2 shows a slight moderation in pricings. ...
2026-06-30 at 5:14pm
Osprey Acquisition Corp. III (NASDAQ:OSPRU) announced the pricing of its $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "OSPRU" on Wednesday, July 1, 2026. ...
2026-06-30 at 12:05pm
Five de-SPAC'd companies and five sponsors are each coming released from their lock-up agreements through the month of July, representing a slate of companies generally on the smaller-cap side of the market. ...
2026-06-29 at 7:33pm
Ares Acquisition Corporation III (NYSE:AAC.U) announced the pricing of its upsized $345 million IPO and its units are expected to begin trading on the NYSE under the symbol "AAC.U" on Tuesday, June 30, 2026. ...
2026-06-29 at 3:39pm
AMR Resources (NASDAQ:AMACU) has filed for a $250 million SPAC with an eye on a deal in the mineral resources sector. The new SPAC is offering investors a 1/2 warrant in each unit, and a large part of its public offering is already accounted for. ...
2026-06-29 at 12:26pm
JATT II (NASDAQ:JATT) has entered into a definitive agreement to combine with biotech firm Talawar Tx at a total equity value of $451.9 million. Talawar Tx is developing a range of drug candidates to potentially treat atopic dermatitis and other immunological disorders, with its lead candidate expected to enter Phase I in early 2027. ...
2026-06-29 at 8:24am
At the SPAC of Dawn With futures green, SPACs have a modest slate of business for the final days of the month, but four SPACs are still scheduled to hold shareholder votes this week. ...
2026-06-27 at 10:02am
Terms Tracker for the Week Ending June 26, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. This will be a short one this week, as we’re hard at work putting together our Q2-2026 report. ...